-
Hospital-Level Effects on Cardiovascular Monitoring Among Cancer Patients Treated with Cardio-Toxic Therapies
Mar 10, 2025, 14:00 PM -
Modeling the Path to Cure: How (NEO)Adjuvant Drug Therapies are Evaluated in Health Technology Assessment (HTA)
Mar 10, 2025, 14:00 PM -
Validation of Real-World Recurrence-Free Survival (rwRFS) and Distant Metastasis-Free Survival(rwDMFS) Endpoints in Early-Stage Melanoma
Mar 10, 2025, 14:00 PM -
Incorporating Best-Worst Scaling into Attribute Selection for Stated Preference Research: A Study Based on Preference for Choosing Antidepressants
Mar 10, 2025, 14:00 PM -
Medical Record Review to Characterize the Foundational Insights and Costs Associated with Intracerebral Hemorrhage (ICH) Management Among Ticagrelor-Treated Patients
Mar 10, 2025, 14:00 PM -
Analysis of NICE Assessments for Orphan Treatments and Key Drivers for Decision-Making
Mar 10, 2025, 14:00 PM -
Characterizing the Impact of Work Productivity of Patients With DMD and Their Caregivers: A Societal Perspective
Mar 10, 2025, 14:00 PM -
Healthcare Resource Utilization 12 Months Following Initiation of Olanzapine/Samidorphan: Real-World Assessment of Patients With Bipolar I Disorder
Mar 10, 2025, 14:00 PM -
Belantamab Mafodotin, Pomalidomide, and Dexamethasone (BPd) in Relapsed/Refractory Multiple Myeloma (RRMM): Quality-Adjusted Life-Year (QALY) Results From a Cost-Effectiveness Model
Mar 10, 2025, 14:00 PM -
Factors Delaying the Public Listing of New Drugs in Canada
Mar 10, 2025, 14:00 PM -
Developing a Selection Framework for Comparator in HTA-Based Inclusion in China's National Reimbursement Drug List
Mar 10, 2025, 14:00 PM -
Relationship Between Patient Engagement and Weight Management in a Pharmacist-led Clinic within a Managed Care Organization
Mar 10, 2025, 14:00 PM -
Use of Logistic Regression to Evaluate All-Cause Readmission and Acute Renal Failure Rates for Infrarenal Fixation Device Family with ePTFE (Device A) Versus Two Suprarenal Fixation Devices with DACRON Material (Device B and C)
Mar 10, 2025, 14:00 PM -
Do Lifetables Overestimate Non-Cancer-Specific Survival (NCSS) in Oncology? A Case Study From Treatment-Naïve Advanced Melanoma
Mar 10, 2025, 14:00 PM -
Clinical and Economic Outcomes of Ultrasonic Energy Devices Used in Patients Treated With Sleeve Gastrectomy
Mar 10, 2025, 14:00 PM -
Economic Modelling of Myopia Management: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Using the Potential Outcomes Model to Inform the Design and Interpretation of Causal Studies of the Effectiveness and Safety of Healthcare Interventions: An Interdisciplinary Perspective
Mar 10, 2025, 14:00 PM -
Changes in Functional Status, Work Productivity, and Daily Activities in People With Idiopathic Hypersomnia and Narcolepsy Treated With Low-Sodium Oxybate: Results From the Phase 4 DUET Study
Mar 10, 2025, 14:00 PM -
More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives
Mar 10, 2025, 14:00 PM -
A Growing Trend: The Expanding Use of Patient-reported Outcome Measures (PROMs) in Clinical Trials (2008-2023)
Mar 10, 2025, 14:00 PM
